Albert Kim
Foot & Ankle Surgery · Rancho Cucamonga, CANPI 1730475732
Payments from drug & device makers
Across 75 payments — averaging $63.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$3K
- Linvatec Corporation$289
- Johnson & Johnson$220
- KCI USA, Inc.$213
- Acera Surgical, Inc.$158
- Amniox Medical, Inc.$154
- plus $838 from 15 others
What the payments were for
- Food & beverage$4,749100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 39 | $2,877 |
| Linvatec Corporation | 2 | $289 |
| Johnson & Johnson | 4 | $220 |
| KCI USA, Inc. | 2 | $213 |
| Acera Surgical, Inc. | 1 | $158 |
| Amniox Medical, Inc. | 1 | $154 |
| Osiris Therapeutics Inc. | 1 | $125 |
| Organogenesis Inc. | 1 | $105 |
| Cardiovascular Systems Inc. | 1 | $96 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $82 |
| Stryker | 1 | $71 |
| Smith+Nephew | 5 | $65 |
| Amgen | 3 | $57 |
| Bioventus LLC | 3 | $56 |
| Tactile Systems Technology Inc | 3 | $52 |
| Integra Lifesciences Corporation | 2 | $37 |
| Nevro Corp. | 1 | $26 |
| Medtronic | 1 | $26 |
| Reprise Biomedical, Inc. | 1 | $19 |
| Sandoz | 1 | $13 |
| Bard Peripheral Vascular, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stratum Foot Plating System$237
- Juggerknot-Foot & Ankle$221
- Restrata Wound Matrix$158
- NEOX$154
- CLARIX$154
- BioBrace 23mm$151
- Foot & Ankle Product Portfolio$126
- Stravix$125
- Grafix$125
- GrafixPL$125
- DYNACORD$124
- Sub Talar Arthrodesis Instr$117
- ACTIV.A.C.$113
- PROMOGRAN PRISMA$113
- V.A.C. VERAFLO$113
- PuraPly$105
- Ace Fischer Frame$103
- Phoenix TTC Instruments and Nail$102
- Nextremity Nextra Hammertoe$100
- SNAP$100
How this compares
$4,749 in reported general payments places this provider in the 70th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Econazole Nitrate | 54 | $2,418 |
| Ketoconazole | 32 | $1,045 |
| Terbinafine Hcl | 92 | $654 |
| Cephalexin | 43 | $289 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $83 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Rancho Cucamonga
- John ZimmermanBakersfield$4.6M
- Eric GizaSacramento$3.7M
- Thomas HarrisPasadena$3M
- Felix SigalLos Angeles$2.2M
- Thomas ChangSanta Rosa$2.1M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.